Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease.
about
Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advicesReproducibility of SELDI Spectra Across Time and LaboratoriesAutomated assignment of ionization states in broad-mass matrix-assisted laser desorption/ionization spectra of protein mixtures.Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers.Human body fluid proteome analysis.Biomarker discovery in infectious diseases using SELDI.Optimization of MALDI-TOF MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100 kDa mass range.Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations.SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerA Bayesian network approach to feature selection in mass spectrometry dataImproved signal processing and normalization for biomarker protein detection in broad-mass-range TOF mass spectra from clinical samples.A SELDI mass spectrometry study of experimental autoimmune encephalomyelitis: sample preparation, reproducibility, and differential protein expression patterns.Bioinformatics approaches in clinical proteomics.Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).A plasma diagnostic model of human T-cell leukemia virus-1 associated myelopathyPreapoptotic protease calpain-2 is frequently suppressed in adult T-cell leukemia
P2860
Q28287384-428F0373-4646-4AF9-859B-C71A99C91423Q30484977-05C9C43C-8B4F-46B2-8CAF-581339806457Q30953230-F10D8A4B-2807-4332-B847-0C913E90DA20Q31033564-8C92486E-6861-4C11-8EE9-B45D738A4E37Q33246070-08F825EC-1DDA-4712-949E-C029A7CE153DQ33262623-676988C7-7FD5-41B9-994B-88E1965F250BQ33292219-41DEE6C9-B7A5-4F6D-8EA8-C3CD5C14B608Q33301709-04D15C66-3ED8-4531-8D95-DCA5F7863242Q33304365-DC34C6FD-55F0-4895-AA2C-0E9BAB12F097Q33306300-CED4C99C-D2AF-4D04-B2F4-93B0D18B61FEQ33551051-1F27A45D-6529-4410-BCAC-12288643EE1AQ33959634-F4272125-AED0-4A36-80F5-C8CBDA159194Q34698979-8126254B-D67D-4FF0-ADB6-C6A65ABCC89EQ36322145-46FAC0A4-977A-404E-8965-66ABE8F68DE5Q36967203-A967D7DC-C041-4C6E-9F85-1E68EADB2C79Q39095729-996AB580-E59A-4C4D-93A2-AF4CAC79CA7FQ39095736-E0684CB5-C85C-4EC5-A04A-BCD4439C3520
P2860
Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Discrete serum protein signatu ...... ologic and neurologic disease.
@ast
Discrete serum protein signatu ...... ologic and neurologic disease.
@en
type
label
Discrete serum protein signatu ...... ologic and neurologic disease.
@ast
Discrete serum protein signatu ...... ologic and neurologic disease.
@en
prefLabel
Discrete serum protein signatu ...... ologic and neurologic disease.
@ast
Discrete serum protein signatu ...... ologic and neurologic disease.
@en
P2093
P2860
P356
P1433
P1476
Discrete serum protein signatu ...... tologic and neurologic disease
@en
P2093
Jacobson S
Trosset MW
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403781
P577
2005-07-01T00:00:00Z
P5875
P6179
1006031127